Physician profile
Sergey Koyfman
NPI 1114067501
$3,254.73
in general payments reported to CMS, 2019-2025
19 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $300 · 2021: $175 · 2022: $198 · 2023: $347 · 2024: $879 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,280.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $939.77 | 2023-2025 | Inspire |
| Intersect Ent, INC. | $604.72 | 2019-2022 | |
| Aerin Medical INC. | $435.89 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $209.40 | 2024-2025 | |
| Glaxosmithkline, LLC. | $191.49 | 2023-2025 | Nucala |
| Optinose US, INC. | $159.78 | 2019-2023 | |
| Genzyme Corporation | $157.63 | 2019-2024 | |
| Medtronic, INC. | $146.24 | 2023-2024 | Novapak, Sinuva |
| Takeda Pharmaceuticals U.S.A., INC. | $74.77 | 2024-2025 | Cuvitru |
| Acclarent, INC | $66.12 | 2021-2023 | Acclarent Navwire |
| Ars Pharmaceuticals Operations, INC. | $54.94 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $40.38 | 2024 | Coolseal Generator |
| Karl Storz Endoscopy-America | $35.68 | 2023 | N.A. |
| Ascendis Pharma Endocrinology INC | $29.59 | 2025 | Yorvipath |
| Baxter Healthcare | $26.87 | 2024 | Floseal |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $25.94 | 2021 | |
| Merck Sharp & Dohme LLC | $21.98 | 2023 | |
| Stryker Corporation | $16.80 | 2019 | |
| Amgen INC. | $16.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Koyfman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.